Synapse

← Thomas A. Wadden

Papers by Thomas A. Wadden

Page 1 · newest first

  1. Lifestyle Modification and Incretin Therapy for Individuals With Obesity—ReplyJAMA · 2026
  2. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in AdultsCirculation · 2013
  3. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in AdultsJournal of the American College of Cardiology · 2013
  4. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular RiskCirculation · 2013
  5. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular RiskJournal of the American College of Cardiology · 2013
  6. Brain activity associated with breakthrough food preoccupation in an individual on tirzepatideNature Medicine · 2025
  7. Internalized weight stigma, metabolic syndrome, and inflammation in postmenopausal women with obesityBrain Behavior & Immunity - Health · 2025
  8. Feasibility and Acceptability of a Psychological Intervention for Internalized Health-Related Stigma Among Adults With Chronic Health Conditions: Preliminary InvestigationJMIR Formative Research · 2025
  9. Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight LossClinical Obesity · 2025
  10. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2025
  11. Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trialNature Medicine · 2025
  12. Characterising first, recent and worst experiences of weight stigma in a clinical sample of adults with high body weight and high internalised stigmaClinical Obesity · 2025
  13. Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET studyObesity · 2025
  14. Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET studyObesity Pillars · 2025
  15. Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS ScaleSHILAP Revista de lepidopterología · 2024
  16. Longitudinal associations of internalized weight stigma with physical activity and weight lossObesity Science & Practice · 2024
  17. Neural Responses to Auditory Food Stimuli Following Cognitive Behavioral Therapy for Binge‐Eating DisorderInternational Journal of Eating Disorders · 2024
  18. Nutritional considerations with antiobesity medicationsObesity · 2024
  19. Long‐term sustained effects of the Look AHEAD lifestyle intervention on body composition among adults with type 2 diabetesObesity · 2024
  20. Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trialsDiabetes Obesity and Metabolism · 2024
  21. The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical OpportunitiesCurrent Obesity Reports · 2023
  22. Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysisObesity · 2023
  23. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialNature Medicine · 2023
  24. Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream?SLEEP · 2023
  25. Long-term effects of an internalized weight stigma intervention: A randomized controlled trial.Journal of Consulting and Clinical Psychology · 2023
  26. Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5Obesity · 2023
  27. Weight changes during the COVID‐19 shutdown in older individuals with type 2 diabetes: the Look AHEAD StudyObesity · 2022
  28. Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special ConsiderationsDrug Design Development and Therapy · 2022
  29. Psychological resilience in older adults with type 2 diabetes from the Look AHEAD TrialJournal of the American Geriatrics Society · 2022
  30. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialNature Medicine · 2022
  31. Steady progress in the behavioral management of obesity in primary‐care settings — but innovation neededObesity · 2022
  32. A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorderObesity Science & Practice · 2022
  33. Binge eating disorder and eating self‐efficacy in adults seeking bariatric surgeryClinical Obesity · 2022
  34. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extensionDiabetes Obesity and Metabolism · 2022
  35. Weight Change During the Postintervention Follow-up of Look AHEADDiabetes Care · 2022
  36. Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD StudyDiabetes Care · 2022
  37. The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle interventionObesity · 2021
  38. Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD StudyDiabetes Care · 2021
  39. Is weight stigma associated with physical activity? A systematic reviewObesity · 2021
  40. The Association of Prior Intensive Lifestyle Intervention and Diabetes Support and Education With Frailty Prevalence at Long-Term Follow-Up in the Action for Health in Diabetes Extension StudyThe Journals of Gerontology Series A · 2021
  41. Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight lossDiabetes Obesity and Metabolism · 2021
  42. Changes in mood and health‐related quality of life in Look AHEAD 6 years after termination of the lifestyle interventionCivil War Book Review · 2021
  43. A systematic review of binge eating, loss of control eating, and weight loss in children and adolescentsObesity · 2021
  44. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityJAMA · 2021
  45. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or ObesityJAMA · 2021
  46. Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine · 2021
  47. Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing dataENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
  48. Dietary interventions for obesity: clinical and mechanistic findingsJournal of Clinical Investigation · 2021
  49. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) StudyDiabetes Care · 2020
  50. Six‐Month Follow‐up from a Randomized Controlled Trial of the Weight BIAS ProgramObesity · 2020